1. Ackenheil, M., Beckmann, H., Greil, W., Hoffmann, G., Markianos, E., Raese, J.: Antipsychotic efficacy of clozapine in correlation to changes in catecholamine metabolism in man. In: The phenothiazines and structurally related drugs, I. S. Forrest, C. J. Carr and E. Usdin, eds., pp. 647?657. New York: Raven Press 1974
2. Andén, N. E., Fuxe, K.: A new dopamine-?-hydroxylase inhibitor: effects on the noradrenaline concentration and on the action of l-Dopa in the spinal cord. Brit. J. Pharmacol. 43, 747?756 (1971)
3. Angrist, B., Lee, H. K., Gershon, S.: The antagonism of amphetamine induced symptomatology by a neuroleptic. Amer. J. Psychiat. 131, 817?819 (1974)
4. Axelrod, J.: Dopamine-?-hydroxylase: Regulation of its synthesis and release from nerve terminals. Pharmacol. Rev. 24, 233?243 (1972)
5. Carlsson, A.: Amphetamine and brain catecholamines. In: Amphetamines and related compounds. E. Costa and S. Garattini, eds., pp. 289?300. New York: Raven Press 1970